Vira Therapeutics

Develops highly potent anti-cancer therapeutics based on oncolytic viruses - making cancer immunotherapies more powerful.

Launch date

Jun 2015

Employees

Market cap

Enterprise valuation

$231m (Public information from Sep 2018)

Company register number FN 397151 x (Innsbruck)

Innsbruck Tyrol (HQ)

http://www.viratherapeutics.com/

https://www.linkedin.com/company/viratherapeutics-gmbh/

View job openings

Revenues, earnings & profits over time

EUR	2021	2022	2023
Profit	<1m	3.6m	2.5m

Date	Investors	Amount	Round
Jan 2013*	Medical University of Innsbruck	N/A	Spinout
Jun 2015	Austria Wirtschaftsservice Boehringer Ingelheim Venture Fund EMBL Ventures	€3.6m	Series A
Sep 2018*	Boehringer Ingelheim	€210m Valuation: €210m	Acquisition
Total Funding		$4.0m

Tech stackLearn more about the technologies and tools that this company uses.